“…Thus, both dorsal and ventral hippocampal muscimol infusions disrupted contextual fear conditioning when the resulting conditioned context fear in the control group was relatively moderate (20-50% freezing) (present study, Experiments 2 and 3, 0.5 µg / 0.5 µl / side; Esclassan et al, 2009, 0.25 µg / 0.25 µl / side), whereas neither dorsal nor ventral hippocampal muscimol infusions affected contextual fear conditioning when conditioning resulted in stronger conditioned freezing (50-70%) (Maren & Holt, 2004, 0.25 µg / 0.25 µl / side;Matus-Amat et al, 2004, 0.5 µg / 0.5 µl / side;Biedenkapp and Rudy, 2008, 0.5 µg / 1 µl / side) (with the exception of Wang et al (2012), who reported anterograde context fear deficits following dorsal hippocampal muscimol (0.5 µg / 0.5 µl / side) with context freezing levels of nearly 60%). That dorsal and ventral hippocampal muscimol infusions cause anterograde deficits in contextual fear conditioning, depending on the strength of the conditioing is consistent with the following view: i) contextual fear conditioning normally requires dorsal and ventral hippocampus (with dorsal hippocampus mediating the formation of contextual representations and ventral hippocampus relating these representations to fear processing via subcortical sites, such as the amygdala; Maren and Fanselow, 1995;Anagnostaras et al, 2001;Bast et al, 2001a;Bannerman et al, 2004;Fanselow & Dong, 2010); ii) an alternative extra-hippocampal system can support contextual fear conditioning, but is less efficient than the hippocampus and, thus, is not able to sustain conditioning under more demanding circumstances, such as those that would result in weak contextual fear (Fanselow, 2010). The strength of conditioning may also partly determine whether or not ventral hippocampal muscimol infusions disrupt tone fear conditioning.…”